Published in World J Gastroenterol on September 28, 2013
Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy. PLoS One (2014) 0.87
The hematopoietic system in the context of regenerative medicine. Methods (2015) 0.84
What's new in clinical solid organ transplantation by 2013. World J Transplant (2014) 0.81
Comparison of the effect of bone marrow cells infusion through the portal vein and inferior vena cava combined with short-term rapamycin on allogeneic islet grafts in diabetic rats. J Diabetes Investig (2016) 0.75
Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32
Actively acquired tolerance of foreign cells. Nature (1953) 19.82
Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24
Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med (2001) 7.86
Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature (1984) 4.26
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Skin transplantation to monitor clinical donor-related tolerance in mixed hematopoietic chimerism. Pediatr Transplant (2006) 2.65
Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet (2001) 2.35
Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl (2004) 2.31
T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology (2006) 2.30
Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination. Am J Transplant (2011) 2.26
Weaning of immunosuppression in living donor liver transplant recipients. Transplantation (2001) 2.18
Transplantation tolerance from a historical perspective. Nat Rev Immunol (2001) 2.04
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81
Tacrolimus: a further update of its use in the management of organ transplantation. Drugs (2003) 1.72
Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am J Pathol (2003) 1.69
Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant (2007) 1.69
Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Liver Transpl (2006) 1.57
Liver sinusoidal endothelial cells are insufficient to activate T cells. J Immunol (2004) 1.39
Repopulation of liver endothelium by bone-marrow-derived cells. Lancet (2001) 1.39
An appraisal of tolerance in liver transplantation. Am J Transplant (2006) 1.32
Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol (2002) 1.28
High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR-analysis. Hepatology (2002) 1.24
Host repopulation of the endothelium in allografts of kidneys and aorta. Surg Forum (1969) 1.18
Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation (1995) 1.14
Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation (1984) 1.11
Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression. Transplantation (2003) 1.08
Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07
Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem-cell transplantation in comparison with cardiac allografts. Transplantation (2004) 1.04
The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant (2005) 1.01
Composite tissue allotransplantation: past, present and future-the history and expanding applications of CTA as a new frontier in transplantation. Transplant Proc (2009) 0.97
Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients. Transplant Proc (2005) 0.97
Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation. Liver Transpl (2010) 0.93
Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl Int (2008) 0.91
The hepatic immune system. Crit Rev Immunol (2002) 0.90
Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells. Blood (2002) 0.90
Long-term follow-up of donor chimerism and tolerance after human liver transplantation. Liver Transpl (2009) 0.90
Spontaneous acceptance of liver allografts in the rat. Analysis of the immune response. Transplantation (1994) 0.89
Liver tolerance mediated by antigen presenting cells: fact or fiction? Gut (2003) 0.89
Composite tissue allotransplantation: current challenges. Transplant Proc (2009) 0.87
Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone. Transplantation (2009) 0.87
Donor bone marrow transplantation: chimerism and tolerance. Transpl Immunol (2004) 0.86
Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft. Transpl Immunol (2004) 0.84
Spontaneous acceptance of liver transplants in rodents: evidence that liver leucocytes induce recipient T-cell death by neglect. Immunol Cell Biol (2002) 0.84
Viability of sinusoidal lining cells in cold-preserved rat liver allografts. Transplantation (1990) 0.84
The future of transplantation: with particular reference to chimerism and xenotransplantation. Transplant Proc (1997) 0.83
Immunological tolerance and liver transplantation. J Hepatol (2004) 0.82
Chimerism and bone marrow based therapies in transplantation. Microsurgery (2007) 0.80
Inducing mixed chimerism and transplantation tolerance through allogeneic bone marrow transplantation with costimulation blockade. Methods Mol Biol (2007) 0.80
Frequent hepatocyte chimerism in long-term human liver allografts independent of graft outcome. Transpl Immunol (2012) 0.79
Evolution of immunosuppression in liver transplantation: contribution of cyclosporine. Transplant Proc (2004) 0.79
Toward tolerance: lessons learned from liver transplantation. Liver Transpl Surg (1999) 0.79
[Tolerance and chimerism in liver transplantation]. Rev Esp Enferm Dig (2007) 0.79
Peripheral blood chimerism following human liver transplantation. Hepatology (1997) 0.79
Immunosuppression withdrawal after liver transplantation: what are the next steps? Transplantation (2011) 0.79
Holey endothelium: gateways for naïve T cell activation. Hepatology (2006) 0.78
Reverse chimerism: stem cells going the other way. Am J Transplant (2011) 0.78
Conversion of pancreas allograft rejection to acceptance by liver transplantation. Transplantation (1998) 0.77
Long-term chimerism in liver transplantation: no evidence for immunological relevance but requirement for graft persistence. Transplant Proc (1995) 0.77
Full donor chimerism using stem-cell transplantation for tolerance induction in the human leukocyte antigen-matched liver transplant setting. Transplantation (2009) 0.76
Immunoregulation in the liver and its extrahepatic relevance. J Pediatr Gastroenterol Nutr (2004) 0.76
A prospective analysis of the natural course of donor chimerism including the natural killer cell fraction after liver transplantation. Transplantation (2011) 0.76
Transplantation tolerance induced by mixed chimerism. J Heart Lung Transplant (2001) 0.76
Donor peripheral blood stem cell infusions in recipients of living-related liver allografts. Transplantation (1997) 0.76
Establishment of chimerism in donor liver with recipient-type bone marrow cells prior to liver transplantation produces marked suppression of allograft rejection in rats. Transpl Int (1998) 0.76
Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J Gastroenterol (2004) 1.02
Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J Gastroenterol (2003) 0.99
Anti-hepatoma activity of resveratrol in vitro. World J Gastroenterol (2002) 0.97
Effect of NF-kappaB and p38 MAPK in activated monocytes/macrophages on pro-inflammatory cytokines of rats with acute pancreatitis. World J Gastroenterol (2003) 0.94
Reoperation for benign biliary tract diseases in 149 cases: causes and prevention. Hepatobiliary Pancreat Dis Int (2004) 0.89
The role of inflammatory mediators in severe acute pancreatitis and regulation of glucocorticoids. Hepatobiliary Pancreat Dis Int (2003) 0.88
Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism. Hepatogastroenterology (2011) 0.87
Resveratrol prolongs allograft survival after liver transplantation in rats. World J Gastroenterol (2005) 0.83
Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer. World J Gastroenterol (2003) 0.82
Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma. World J Gastroenterol (2003) 0.81
[Expression of heparanase and nuclear factor kappa B in pancreatic adenocarcinoma]. Nan Fang Yi Ke Da Xue Xue Bao (2007) 0.79
[Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells]. Zhong Xi Yi Jie He Xue Bao (2008) 0.78
Management of spontaneous rupture of hepatocellular carcinoma. ANZ J Surg (2008) 0.78
[Radiosensitization of beta-elemene on VX2 carcinoma transplanted on kidney in rabbits in vivo]. Zhong Xi Yi Jie He Xue Bao (2006) 0.78
Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis. Hepatobiliary Pancreat Dis Int (2003) 0.78
Apoptosis of lymphocytes in allograft in a rat liver transplantation model induced by resveratrol. Pharmacol Res (2006) 0.78
Iatrogenic bile duct injuries from biliary tract surgery. Hepatobiliary Pancreat Dis Int (2007) 0.78
Effects of Antiadhesion preparation on free fibrinogen and fibrin degrading products in abdominal exudates of rabbits postoperatively. World J Gastroenterol (2004) 0.77
[Research of beta-elemene interventional treatment on VX2 carcinoma transplanted on kidney in rabbits]. Zhong Xi Yi Jie He Xue Bao (2006) 0.77
[Construction and identification of recombinant adeno-associated virus vector harboring fusion gene NT4-Ant-Shepherdin[79-87]]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2008) 0.77
Dexamethasone and dextran 40 treatment of 32 patients with severe acute pancreatitis. World J Gastroenterol (2004) 0.77
Effects of emodin and double blood supplies on liver regeneration of reduced size graft liver in rat model. World J Gastroenterol (2005) 0.76
[Resveratrol increases sensitivity of CNE2 cells to chemotherapeutic drugs under hypoxia]. Zhong Xi Yi Jie He Xue Bao (2009) 0.75
Microcirculation disturbance affects rats with acute severe pancreatitis following lung injury. World J Gastroenterol (2005) 0.75
[Efficacy of modified acupotome combined with blocking therapy in patients with carpal tunnel syndrome]. Zhong Xi Yi Jie He Xue Bao (2006) 0.75
[The construction and expression of a hepatocellular carcinoma-specific superantigen SEA (D227A) expression vector]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2003) 0.75
Lamivudine in prevention and treatment of recurrent HBV after liver transplantation. Hepatobiliary Pancreat Dis Int (2004) 0.75
[Impact of preoperative lymphatic chemotherapy on relapse and metastasis of breast cancer and its mechanism]. Ai Zheng (2005) 0.75